DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,857,888 | -1.6% | 23,611 | -4.8% | 0.14% | -19.2% |
| Q2 2023 | $5,952,000 | -14.4% | 24,800 | -10.1% | 0.17% | -4.0% |
| Q1 2023 | $6,954,790 | -8.7% | 27,594 | -3.9% | 0.17% | -14.7% |
| Q4 2022 | $7,620,000 | +9.9% | 28,709 | +6.9% | 0.20% | +2.0% |
| Q3 2022 | $6,935,000 | +1.3% | 26,857 | -0.6% | 0.20% | +14.9% |
| Q2 2022 | $6,849,000 | -11.5% | 27,023 | +2.5% | 0.17% | +6.7% |
| Q1 2022 | $7,736,000 | -12.9% | 26,373 | -2.3% | 0.16% | -7.4% |
| Q4 2021 | $8,879,000 | +8.7% | 26,988 | +0.6% | 0.18% | 0.0% |
| Q3 2021 | $8,167,000 | +20.2% | 26,825 | +5.9% | 0.18% | +18.1% |
| Q2 2021 | $6,796,000 | +19.2% | 25,330 | 0.0% | 0.15% | +18.3% |
| Q1 2021 | $5,700,000 | -0.4% | 25,330 | -1.7% | 0.13% | -14.3% |
| Q4 2020 | $5,724,000 | +61.3% | 25,765 | +56.3% | 0.15% | +38.7% |
| Q3 2020 | $3,549,000 | +20.1% | 16,487 | -1.3% | 0.11% | +7.1% |
| Q2 2020 | $2,955,000 | +718.6% | 16,712 | +539.1% | 0.10% | +560.0% |
| Q1 2020 | $361,000 | -21.7% | 2,615 | -13.0% | 0.02% | -16.7% |
| Q4 2019 | $461,000 | +16.4% | 3,005 | +9.5% | 0.02% | +5.9% |
| Q3 2019 | $396,000 | +1.0% | 2,745 | 0.0% | 0.02% | +6.2% |
| Q2 2019 | $392,000 | -4.6% | 2,745 | -12.0% | 0.02% | -5.9% |
| Q1 2019 | $411,000 | +83.5% | 3,119 | +43.0% | 0.02% | +88.9% |
| Q4 2018 | $224,000 | -58.0% | 2,181 | -55.6% | 0.01% | -52.6% |
| Q3 2018 | $533,000 | +80.7% | 4,912 | +64.3% | 0.02% | +72.7% |
| Q2 2018 | $295,000 | +10.1% | 2,990 | +9.2% | 0.01% | +10.0% |
| Q1 2018 | $268,000 | -47.0% | 2,738 | -50.0% | 0.01% | +11.1% |
| Q4 2017 | $506,000 | +65.4% | 5,476 | +53.8% | 0.01% | -18.2% |
| Q3 2017 | $306,000 | -82.1% | 3,561 | -82.4% | 0.01% | -81.4% |
| Q2 2017 | $1,709,000 | -1.2% | 20,261 | +0.2% | 0.06% | +1.7% |
| Q1 2017 | $1,730,000 | -24.7% | 20,220 | -31.4% | 0.06% | -13.4% |
| Q4 2016 | $2,296,000 | +20.6% | 29,495 | +21.4% | 0.07% | +19.6% |
| Q3 2016 | $1,904,000 | -4.0% | 24,297 | +23.7% | 0.06% | -3.4% |
| Q2 2016 | $1,984,000 | +3.4% | 19,647 | -3.0% | 0.06% | -1.7% |
| Q1 2016 | $1,919,000 | -5.2% | 20,247 | -7.2% | 0.06% | -7.8% |
| Q4 2015 | $2,024,000 | +284.1% | 21,817 | +253.4% | 0.06% | +204.8% |
| Q3 2015 | $527,000 | -18.9% | 6,174 | -18.8% | 0.02% | -12.5% |
| Q2 2015 | $650,000 | -58.5% | 7,600 | -58.8% | 0.02% | -59.3% |
| Q1 2015 | $1,566,000 | +25.0% | 18,465 | +26.2% | 0.06% | +1.7% |
| Q4 2014 | $1,253,000 | -17.0% | 14,635 | -26.3% | 0.06% | -4.9% |
| Q3 2014 | $1,510,000 | -13.3% | 19,860 | -10.1% | 0.06% | -11.6% |
| Q2 2014 | $1,741,000 | -27.6% | 22,101 | -31.1% | 0.07% | -31.0% |
| Q1 2014 | $2,406,000 | +26.1% | 32,073 | +29.8% | 0.10% | +25.0% |
| Q4 2013 | $1,908,000 | – | 24,714 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |